2024-09-18 - Analysis Report
##  ISRG Stock Analysis Report

**Company Overview:**

ISRG (Intuitive Surgical, Inc.) is a leading provider of robotic-assisted minimally invasive surgical systems.

**Performance Analysis:**

1. **Return on Investment:**
    - ISRG's cumulative return is 101.37%, outperforming the S&P 500 (VOO) with a cumulative return of 88.56%. 
    - The current outperformance is 12.81%, placing it at the 58.01 percentile of historical performance relative to the S&P 500.

2. **Recent Price Movement:**
    - **Closing Price:** $484.63
    - **5-day Moving Average:** $490.16
    - **20-day Moving Average:** $484.96
    - **60-day Moving Average:** $460.46
    - **Conclusion:** The stock is currently trading slightly below its 5-day and 20-day moving averages, suggesting potential short-term consolidation. The 60-day moving average is below the current price, implying a bullish longer-term trend.

3. **Technical Indicators:**
    - **RSI:** 51.73 (Neutral): The RSI is currently at 51.73, indicating that the stock is neither overbought nor oversold.
    - **PPO:** -0.2 (Slight Sell Signal): The PPO is negative, suggesting a slight sell signal. However, it is important to note that the PPO is very close to zero.
    - **Delta_Previous_Relative_Divergence:** -0.22 (Short-term Downward Trend): The recent 20-day relative divergence indicates a short-term downward trend.
    - **Expected Return:** 17.97% (Maximum 5-year projected return): This suggests a potential for significant growth in the future, based on the current investment amount.

4. **Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-07-24 | 1.2 | 1.76 B$ |
| 2024-07-19 | 1.2 | 1.76 B$ |

- **Recent Earnings:** ISRG's most recent earnings report (2024-07-19) revealed an EPS of $1.48 and revenue of $2.01 Billion. 
- **Analysis:** The company has consistently shown strong revenue growth and exceeded earnings expectations in recent quarters. 
- **Outlook:** Despite potential economic headwinds, ISRG's long-term outlook remains positive, driven by the growing demand for minimally invasive surgeries and the company's dominance in the robotic-assisted surgical market.

**Conclusion:**

ISRG continues to be a strong performer, outperforming the market and showing consistent revenue growth. The technical indicators suggest short-term consolidation, while the long-term trend remains bullish. Although the PPO shows a slight sell signal, this is mitigated by the strong recent earnings and positive future prospects. Given the company's dominance in the robotic surgery market and the growing demand for minimally invasive procedures, ISRG remains an attractive investment opportunity for investors seeking long-term growth.

**Disclaimer:** This is an AI-generated report based on the provided data. This should not be considered financial advice. Consult with a financial advisor before making any investment decisions.